Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05809362
Other study ID # 2000031382
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 10, 2023
Est. completion date January 25, 2024

Study information

Verified date April 2024
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this protocol is to assess the sensitivity and specificity of a photoplethysmography (PPG)-based algorithm for the detection of atrial fibrillation as compared to a gold-standard assessment (wearable ECG patch) among a population of individuals with known atrial fibrillation and without known atrial fibrillation over a 7-day study period.


Description:

Atrial fibrillation (Afib) is the most common cardiac arrhythmia in the United States, affecting up to one in four individuals across the lifespan, and is associated with substantial morbidity and mortality. Fifteen percent of strokes in the United States are attributable to Afib, and nearly 20% of these occur in individuals with no prior Afib history. Because Afib is often paroxysmal, one-time screening is unlikely to capture those at risk. Thus, there has been an increasing interest in leveraging monitoring for Afib via wearable devices, which provide a novel method to detect Afib and determine the burden of Afib in the general population. Devices such as the WHOOP 4.0 strap use advanced sensors to detect pulse rate and other physiologic metrics in real-time. Given the high degree of pulse-rate variability in Afib, it is clear that algorithms evaluating data from these devices may be able to detect asymptomatic Afib. However, the sensitivity and specificity of the algorithm operating on data from the WHOOP 4.0 strap have not been formally evaluated in a clinical setting. The WHOOP strap measures changes in blood flow via photoplethysmography (PPG), from which timing between successive heartbeats ("beat-to-beat intervals") is measured. While normal sinus rhythm tends to display beat-to-beat intervals of similar magnitude, those of cardiac arrythmias are characterized by higher variability and may follow particular patterns. The primary objective of this study is to assess the sensitivity and specificity of the WHOOP Strap ANF 1.0 classification algorithm for the detection of Afib as compared to a gold-standard assessment (one-week ECG patch monitoring using the BioTel ePatch).


Recruitment information / eligibility

Status Completed
Enrollment 653
Est. completion date January 25, 2024
Est. primary completion date January 25, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria: - Age >= 22 years - Known diagnosis of atrial fibrillation OR no history of arrhythmia as documented in the patient medical record - Seen in a Yale New Haven Hospital-associated Primary Care or Cardiology Clinic - Cell phone (IOS 15.0 or greater or Android 10 or greater) with an active data plan and willing to install the WHOOP Mobile Application software - Full-time US resident - Able to read, understand, and provide written informed consent in English - Willing and able to participate in the study procedures as described in the consent form - Able to communicate effectively with and follow instructions from the study staff Exclusion Criteria: - Pre-existing WHOOP user with active account - Has implantable cardiac device (e.g., pacemaker, ICD, LVAD) - Solid organ transplant - Sensitivity or allergy to ECG patch or skin glue - Unwilling to wear WHOOP 4.0 strap for one week - Unwilling to wear BioTel (ECG patch) ePatch for one week - WHOOP strap should be the only wearable on the arm. Individuals unwilling to adhere to the proper usage of the WHOOP strap will be excluded. - Unwilling to install the WHOOP Mobile Application software - Unable to provide informed consent - Non-English speaking (as the WHOOP Mobile Application software is English only) - Known sensitivity to medical adhesives, isopropyl alcohol, watch bands, or electrocardiogram (ECG) electrodes including known allergy or sensitivity to polyamide, polyester, or elastane bands primarily used in wrist worn fitness devices - Symptomatic (or active) allergic skin reactions - Significant tremor that prevents the subject from being able to hold still. - Acute myocardial infarction (MI) within 90 days of screening or other cardiovascular disease that, in the opinion of the investigator, increases the risk to the subject or renders data uninterpretable. - Pregnant women: Women who report being pregnant at the time of study participation. - Subjects taking rhythm control drugs including amiodarone, dronedarone, dofetilide, sotalol, flecainide, ibutilide, lidocaine, procainamide, propafenone, quinidine, tocainide.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
WHOOP 4.0 Strap
Subjects will receive both the WHOOP 4.0 Strap and the BioTel ePatch and will continuously wear each for one week. Data will be collected and analyzed by the study team upon return of the both devices from the subject.
BioTel ePatch
Subjects will receive both the WHOOP 4.0 Strap and the BioTel ePatch and will continuously wear each for one week. Data will be collected and analyzed by the study team upon return of the both devices from the subject.

Locations

Country Name City State
United States Yale University New Haven Connecticut

Sponsors (3)

Lead Sponsor Collaborator
Yale University WHOOP Inc., ZS Associates, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity of the PPG-based WHOOP ANF algorithm for detection of atrial fibrillation Sensitivity is defined as the True Positives/(True Positives + False Negatives). A "true" atrial fibrillation reading will have an ECG patch reading consistent with sustained atrial fibrillation for at least 5 continuous minutes. A WHOOP ANF diagnosis of atrial fibrillation is defined as "atrial fibrillations" being detected using the internal algorithm. A true positive is defined as the count of individuals who have at least 1 window labelled as Afib by WHOOP ANF and which has 5+ minutes of continuous Afib as determined by the BioTel recording and confirmed by tachogram adjudication. A false negative is defined as individuals who do not have any windows labelled by WHOOP-ANF as having Afib but at least one window has 5+ minutes of continuous Afib as determined by the BioTel recording. 7 days of continuous wear of the WHOOP 4.0 Strap and BioTel ePatch immediately post enrollment
Primary Specificity of the PPG-based WHOOP ANF algorithm for detection of atrial fibrillation Specificity is defined as the True Negatives/(True Negatives + False Positives). A "true" atrial fibrillation reading will have an ECG patch reading consistent with sustained atrial fibrillation for at least 5 continuous minutes. A WHOOP ANF diagnosis of atrial fibrillation is defined as "atrial fibrillations" being detected using the internal algorithm. A true negative is defined as the count of individuals who do not have any windows labelled by WHOOP ANF as having Afib and none of these windows contain 5+ minutes of continuous Afib as determined by the BioTel recording. A false positive is defined as individuals who have windows labelled as Afib by WHOOP ANF but none of these windows contain 5 minutes or greater of continuous Afib as determined by BioTel recording or have 5+ minutes of continuous Afib as determined by BioTel recording but none can be verified by tachogram adjudication. 7 days of continuous wear of the WHOOP 4.0 Strap and BioTel ePatch immediately post enrollment
Secondary Concordance between WHOOP ANF and BioTel ePatch via epoch assessment Comparison of each epoch by both WHOOP ANF and the BioTel ePatch for concordance using the following definitions: True Positive: An epoch detected by WHOOP ANF as "atrial fibrillation" that has >=5 mins of AFib as detected by the ECG patch. True Negative: An epoch that is NOT labelled as "atrial fibrillation" by the WHOOP ANF and has < 5 mins of AFib as detected by the ECG patch. Specificity of the algorithm on the epoch level: True Negative/(True Negatives + False Positives). Sensitivity of the algorithm on the epoch level: True Positives / (True Positives + False Negatives). Positive predictive value of the algorithm on the epoch level: True Positives / (True Positives + False Positives). Negative predictive value of the algorithm on the epoch level: True Negatives / (True Negatives + False Negatives). 7 days of continuous wear of the WHOOP 4.0 Strap and BioTel ePatch immediately post enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Completed NCT04571385 - A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) Phase 2
Terminated NCT04115735 - His Bundle Recording From Subclavian Vein
Completed NCT05366803 - Women's Health Initiative Silent Atrial Fibrillation Recording Study N/A
Completed NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Recruiting NCT05442203 - Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease N/A
Completed NCT05599308 - Evaluation of Blood Pressure Monitor With AFib Screening Feature N/A
Completed NCT03790917 - Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
Enrolling by invitation NCT05890274 - Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO N/A
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Recruiting NCT05316870 - Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation N/A
Not yet recruiting NCT06023784 - The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Recruiting NCT04092985 - Smart Watch iECG for the Detection of Cardiac Arrhythmias
Completed NCT04087122 - Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures N/A
Completed NCT06283654 - Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
Recruiting NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04546763 - Study Watch AF Detection At Home
Completed NCT03761394 - Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke N/A